Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial compared ofatumumab and duvelisib for chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). It was for people with CLL or SLL that had come back or continued to grow despite having other treatment.
The trial was open for people to join in 2014 and 2015. The research team published the results in 2018.
Recruitment start: 21 January 2014
Recruitment end: 9 December 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Infinity Pharmaceuticals, Inc
NIHR Clinical Research Network: Cancer
Verastem Oncology
Last reviewed: 20 Sept 2023
CRUK internal database number: 12062
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
